Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-18
SponsorBaskent University
About this trial
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients.
Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Eligibility criteria
Qualifiers
7 to 18 years old,
who will receive intravenous chemotherapy,
no cognitive or neurological disease that would prevent communication,
receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
Disqualifiers
Children receiving radiotherapy,
taking ginger powder or vitamins to reduce nausea,
children who did not want to participate in the study
Trial design
Treatments tested in this trial
- guided imagery
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Baskent University
Lead sponsor
Hacettepe University
Collaborator
Source ClinicalTrials.gov